Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolfgang Wick

Showing results (1-10 of 683) with videos related to

Pageof 69
Sort By:
European Journal of Cancer (Oxford, England : 1990)|September 28, 2011
Anaplastic gliomas: an emerging entityWolfgang Wick
Der Nervenarzt|October 5, 2022
[Disruptive innovations in neuromedicine]Wolfgang Wick
Neuro-Oncology|February 27, 2016
TTFields: where does all the skepticism come from?Wolfgang Wick
Current Opinion in Neurology|September 23, 2009
Classification and management of anaplastic gliomasWolfgang Wick, Michael Weller
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2005
How lymphotoxic is dose-intensified temozolomide? The glioblastoma experienceWolfgang Wick, Michael Weller
Seminars in Neurology|March 17, 2018
Neuro-OncologyTracy Batchelor, Wolfgang Wick
Neuro-Oncology|March 11, 2015
Tregs in gliomas - the jury is still outMichael Platten, Wolfgang Wick
Cancer|April 27, 2018
Regimen of procarbazine, lomustine, and vincristine versus temozolomide for gliomasWolfgang Wick, Frank Winkler
Neuro-Oncology|March 25, 2011
Are we ready to demystify age in glioblastoma? Or does older age matter in glioblastoma?Michael Weller, Wolfgang Wick
Science (New York, N.Y.)|March 29, 2018
Harmful networks in the brain and beyondFrank Winkler, Wolfgang Wick
Pageof 69

Showing results (1-10 of 683) with videos related to

Sort By:
Pageof 69
European Journal of Cancer (Oxford, England : 1990)|September 28, 2011
Anaplastic gliomas: an emerging entityWolfgang Wick
Der Nervenarzt|October 5, 2022
[Disruptive innovations in neuromedicine]Wolfgang Wick
Neuro-Oncology|February 27, 2016
TTFields: where does all the skepticism come from?Wolfgang Wick
Current Opinion in Neurology|September 23, 2009
Classification and management of anaplastic gliomasWolfgang Wick, Michael Weller
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2005
How lymphotoxic is dose-intensified temozolomide? The glioblastoma experienceWolfgang Wick, Michael Weller
Seminars in Neurology|March 17, 2018
Neuro-OncologyTracy Batchelor, Wolfgang Wick
Neuro-Oncology|March 11, 2015
Tregs in gliomas - the jury is still outMichael Platten, Wolfgang Wick
Cancer|April 27, 2018
Regimen of procarbazine, lomustine, and vincristine versus temozolomide for gliomasWolfgang Wick, Frank Winkler
Neuro-Oncology|March 25, 2011
Are we ready to demystify age in glioblastoma? Or does older age matter in glioblastoma?Michael Weller, Wolfgang Wick
Science (New York, N.Y.)|March 29, 2018
Harmful networks in the brain and beyondFrank Winkler, Wolfgang Wick
Pageof 69